Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Falls Short of Nasdaq Listing Requirement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics disclosed after the close of the market on Thursday that it has been told by Nasdaq that it falls short of a listing requirement and could face delisting.

In a document filed with the US Securities Exchange Commission, the Israeli firm said it received a letter from Nasdaq on Dec. 6 saying its stockholders' equity had fallen below the minimum $2.5 million required to remain listed on the Nasdaq Capital market.

As a result, Rosetta Genomics will have to submit a plan to the exchange within 45 days detailing how it will regain compliance. The company said it intends to do so.

If Nasdaq accepts the plan, it can give Rosetta Genomics up to 180 days to carry out its plan. If the plan is found unacceptable, Nasdaq will provide written notice to the company that it is subject to delisting action. Rosetta Genomics can then appeal the decision to a Nasdaq Hearings Panel.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.